Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials

BACKGROUND: Recent studies have shown the efficacy for using spironolactone to treat heart failure with reduced ejection fraction (HFrEF), but the efficacy of spironolactone for heart failure with mid-range ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) is uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yajie, Shi, Wenhai, Li, Zhuolin, Yang, Yunjing, Wang, Stephen Yishu, Xiang, Rui, Feng, Panpan, Wen, Li, Huang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456096/
https://www.ncbi.nlm.nih.gov/pubmed/30921200
http://dx.doi.org/10.1097/MD.0000000000014967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456096/
https://www.ncbi.nlm.nih.gov/pubmed/30921200
http://dx.doi.org/10.1097/MD.0000000000014967

Ejemplares similares